Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Frieman

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature Communications|October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Nature|September 23, 2020
Animal models for COVID-19César Muñoz-Fontela, William E Dowling, Simon G P Funnell, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Science (New York, N.Y.)|October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsDavid E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature Communications|October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Nature|September 23, 2020
Animal models for COVID-19César Muñoz-Fontela, William E Dowling, Simon G P Funnell, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Science (New York, N.Y.)|October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsDavid E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Pageof 11